%A PENG Deng-Fu, WANG Yong, HU Bing %T Clinical applications of raltitrexed in colorectal cancer %0 Journal Article %D 2013 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2013.12.017 %P 933-935 %V 40 %N 12 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9226.shtml} %8 2013-12-10 %X Raltitrexed is a specific inhibitor of thymidylate synthase (TS), which has significant antitumor activity. Overseas and domestic researches show that raltitrexed can be widely applied in clinical treatment for colorectal cancer patients because it is effective, welltolerated and convenient.